ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TuSimple Holdings Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – TSP – QNT Press Release4 years ago
Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress – QNT Press Release4 years ago
Camrelizumab in Combination with Rivoceranib (Apatinib) Significantly Prolonged Overall Survival and Progression-Free Survival vs. Sorafenib in Patients with Unresectable Hepatocellular Carcinoma in a Multinational Phase 3 Trial, a Joint Program with Elevar Therapeutics – QNT Press Release4 years ago
VINFAST DELIVERS THE FIRST 100 VF 8 ALL-ELECTRIC SUVS, AND IS READY FOR GLOBAL EXPORT – QNT Press Release4 years ago
